Header

Header

Pharmas

Latest News

January 5, 2023
118

Pharma’s antibiotic venture fund invests in BioVersys
Latest News

November 10, 2022
138

PACT Pharma’s cancer treatments clear safety hurdles
Latest News

October 27, 2022
153

A new MacArthur ‘genius’ on pharma’s patent games
Latest News

September 15, 2022
163

Pharma’s telehealth gold mine & the return of the biotech IPO
Latest News

July 5, 2022
156

FDA to convene second panel to review Amylyx Pharma’s ALS treatment
Latest News

June 8, 2022
163

User fee bill needs to address pharma’s role in the climate crisis
Latest News

May 21, 2022
152

Outcome of Innate Pharma’s 2022 Annual General Meeting
Latest News

April 26, 2022
167

Covid-19 elevated pharma’s reputation among patient groups. Will it last?
Latest News

April 21, 2022
168

Pharma’s role in value-based care starts with value-based research
Latest News

April 4, 2022
165

Pharma’s ambitious new antibiotic venture fund makes its first investments
Latest News

March 30, 2022
171

Tracking the FDA advisory panel on Amylyx Pharma’s ALS treatment
Latest News

February 26, 2019
143

Opinion: Pharma’s tarnished reputation helps fuel the anti-vaccine movement
Latest News

February 22, 2019
138

LISTEN: Painkiller racketeering, the limits of genetic tests, and pharma’s day on the Hill
Latest News

December 3, 2018
147

STAT Plus: Republican senator: pharma’s arguments against putting drug prices in TV ads are ‘patronizing’
Latest News

September 21, 2018
133

LISTEN: A Hong Kong heat-check, a $20 million wrist slap, and pharma’s (other) diversity problem
Latest News

August 18, 2018
144

LISTEN: A lesson in startup jargon, pharma’s bare Alzheimer’s cupboard, and the cost of CAR-T
Latest News

July 25, 2018
145

Déjà voodoo: Pharma’s promises to curb drug prices have been heard before